Advertisement
Screener

Evome Medical Technologies, Inc. Depreciation and Amortization

Evome Medical Technologies, Inc. Depreciation and Amortization

Evome Medical Technologies, Inc. reported Depreciation and Amortization of CAD 1.00 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-16.

Discontinued › Cash Flow › Operating Activities

us-gaap:DepreciationDepletionAndAmortization · last filed 2024-04-16

  • Evome Medical Technologies, Inc. depreciation, depletion and amortization for the quarter ending 2023-12-31 was 280.20K CAD, a 61.91% decline year-over-year.
  • Evome Medical Technologies, Inc. depreciation, depletion and amortization for the quarter ending 2023-09-30 was -1.35M CAD.
  • Evome Medical Technologies, Inc. depreciation, depletion and amortization for the quarter ending 2023-06-30 was 1.16M CAD, a 185.80% increase year-over-year.
  • Evome Medical Technologies, Inc. depreciation, depletion and amortization for the quarter ending 2023-03-31 was 916.64K CAD, a 147.39% increase year-over-year.
  • Evome Medical Technologies, Inc. depreciation, depletion and amortization for fiscal 2023 was 1.00M CAD.
  • Evome Medical Technologies, Inc. depreciation, depletion and amortization for fiscal 2022 was 841.77K CAD.
  • Evome Medical Technologies, Inc. depreciation, depletion and amortization for fiscal 2021 was 0.00 CAD.
Period endDepreciation, Depletion and Amortization 3 monthDepreciation, Depletion and Amortization 6 monthDepreciation, Depletion and Amortization 9 monthDepreciation, Depletion and Amortization 10 monthDepreciation, Depletion and Amortization 10 month as first filedDepreciation, Depletion and Amortization 12 month
2023-12-31280.20K CAD
derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16
-1.07M CAD
derived: sum of 2 quarters · filed 2024-04-16
85.98K CAD
derived: sum of 3 quarters · filed 2024-04-16
1.00M CAD
10-K · filed 2024-04-16
2023-09-30-1.35M CAD
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14
-194.22K CAD
derived: sum of 2 quarters · filed 2023-11-14
722.42K CAD
10-Q · filed 2023-11-14
2023-06-301.16M CAD
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14
2.07M CAD
10-Q · filed 2023-08-14
2023-03-31916.64K CAD
10-Q · filed 2023-05-15
2022-12-31253.49K CAD
10-K · filed 2024-04-16
1.81M CAD
10-KT · filed 2023-04-03
2022-11-30735.58K CAD
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-01-17
1.59M CAD
10-Q · filed 2023-01-17
2022-09-30-461.39K CAD
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14
313.59K CAD
10-Q · filed 2023-11-14
2022-08-31439.27K CAD
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-10-17
851.92K CAD
10-Q · filed 2022-10-17
2022-06-30404.46K CAD
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14
774.99K CAD
10-Q · filed 2023-08-14
2022-05-31412.65K CAD
10-Q · filed 2022-07-15
2022-03-31370.53K CAD
10-Q · filed 2023-05-15
2022-02-28359.31K CAD
derived: 10-KT 12 month − 10-Q 9 month · filed 2023-04-03
658.14K CAD
derived: sum of 2 quarters · filed 2023-04-03
825.11K CAD
derived: sum of 3 quarters · filed 2023-04-03
841.77K CAD
10-KT · filed 2023-04-03
2021-12-31631.47K CAD
10-KT · filed 2023-04-03
2021-11-30298.83K CAD
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-01-17
465.80K CAD
derived: sum of 2 quarters · filed 2023-01-17
482.45K CAD
10-Q · filed 2023-01-17
482.45K CAD
derived: sum of 4 quarters · filed 2023-01-17
2021-08-31166.97K CAD
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-10-17
183.63K CAD
10-Q · filed 2022-10-17
183.63K CAD
derived: sum of 3 quarters · filed 2022-10-17
183.63K CAD
derived: sum of 4 quarters · filed 2022-10-17
2021-05-3116.66K CAD
10-Q · filed 2022-07-15
16.66K CAD
derived: sum of 2 quarters · filed 2022-07-15
16.66K CAD
derived: sum of 3 quarters · filed 2022-07-15
2021-02-280.00 CAD
derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-31
0.00 CAD
derived: sum of 2 quarters · filed 2022-05-31
0.00 CAD
10-K · filed 2022-05-31
2020-11-300.00 CAD
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-01-14
0.00 CAD
10-Q · filed 2022-01-14
2020-08-310.00 CAD
10-Q · filed 2021-10-15